Sign In
Buy AVEO
$15.00
+0 (+0%)
At Close: Apr 18, 2023
What's in Store for Axsome (AXSM) This Earnings Season?
03:33pm, Monday, 02'nd Mar 2020
On Axsome's (AXSM) fourth-quarter earnings call, investors will look for its progress with the CNS pipeline candidates and the regulatory updates on the same.
What's in Store for Axsome (AXSM) This Earnings Season?
03:33pm, Monday, 02'nd Mar 2020
On Axsome's (AXSM) fourth-quarter earnings call, investors will look for its progress with the CNS pipeline candidates and the regulatory updates on the same.
What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?
03:26pm, Monday, 02'nd Mar 2020
During the Q4 investors' call, Cassava Sciences (SAVA) is likely to provide an update on its lead candidate PT-125, which is being developed for the treatment of Alzheimer's disease.
Onconova (ONTX) to Report Q4 Earnings: What's in Store?
02:54pm, Monday, 02'nd Mar 2020
Onconova (ONTX) will focus on the updates on lead candidate, Rigosertib, when it reports fourth-quarter 2019 results.
What Lies Ahead for Cassava Sciences (SAVA) in Q4 Earnings?
12:00am, Monday, 02'nd Mar 2020The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study
03:39pm, Tuesday, 28'th Jan 2020
AVEO releases results from a phase Ib study on ficlatuzumab in combination with nab-paclitaxel and gemcitabine for treating advanced pancreatic cancer. Shares inch up.
AVEO Posts Data on Ficlatuzumab From Pancreatic Cancer Study
03:39pm, Tuesday, 28'th Jan 2020
AVEO releases results from a phase Ib study on ficlatuzumab in combination with nab-paclitaxel and gemcitabine for treating advanced pancreatic cancer. Shares inch up.
